[Treatment of multiple myeloma with thalidomide and immunomodulatory drugs].
Hattori
Yutaka
Y
Division of Hematology, Department of Medicine, Keio University School of Medicine.
D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*
D007155:Immunologic Factors; D013792:Thalidomide